Evidence map›Paper›PMID 32666402›Full record

ArticleArchives of women's mental health2020

Associations between commonly used patient-reported outcome tools in postpartum depression clinical practice and the Hamilton Rating Scale for Depression.

Margaret E Gerbasi, Adi Eldar-Lissai, Sarah Acaster, Moshe Fridman, Vijayveer Bonthapally, Paul Hodgkins, Stephen J Kanes, Samantha Meltzer-Brody

3 registry-linked trialsOpen access · hybridAbstract read
In one paragraph

Article in Archives of women's mental health, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02614547 phase2completednot on this map

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating The Efficacy, Safety, And Pharmacokinetics Of SAGE-547 Injection In The Treatment Of Adult Female Subjects With Severe Postpartum Depression

TypeinterventionalSponsorSupernus Pharmaceuticals, Inc.Ran2015 to 2016Enrolled21ConditionsSevere Postpartum DepressionArmsSAGE-547, Placebo
NCT02942004 phase3completednot on this map

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression

TypeinterventionalSponsorSupernus Pharmaceuticals, Inc.Ran2016 to 2017Enrolled138ConditionsPostpartum DepressionArmsPlacebo, SAGE-547 60 μg/kg/h, SAGE-547 90 μg/kg/h
NCT02942017 phase3completednot on this map

A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study Evaluating the Efficacy, Safety, and Pharmacokinetics of SAGE-547 Injection in the Treatment of Adult Female Subjects With Severe Postpartum Depression and Adult Female Subjects With Moderate Postpartum Depression

TypeinterventionalSponsorSupernus Pharmaceuticals, Inc.Ran2016 to 2017Enrolled108ConditionsPostpartum DepressionArmsPlacebo, SAGE-547 90 μg/kg/h
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Real-World Outcomes of Brexanolone to Treat Postpartum Depression.Women's health reports (New Rochelle, N.Y.) · 2025
    Article
  3. Article
  4. Observational
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Margaret E GerbasiSage Therapeutics, Inc., Cambridge, MA, USA.
Adi Eldar-LissaiSage Therapeutics, Inc., Cambridge, MA, USA.
Sarah AcasterAcaster Lloyd Consulting Ltd., London, UK.
Moshe FridmanAMF Consulting, Los Angeles, CA, USA.
Vijayveer BonthapallySage Therapeutics, Inc., Cambridge, MA, USA.
Paul HodgkinsSage Therapeutics, Inc., Cambridge, MA, USA.
Stephen J KanesSage Therapeutics, Inc., Cambridge, MA, USA.
Samantha Meltzer-BrodyDepartment of Psychiatry, University of North Carolina School of Medicine, 101 Manning Drive, Chapel Hill, NC, 27514, USA. samantha_meltzer-brody@med.unc.edu.
Sage Therapeutics (United States) · USLloyd's · GBUniversity of North Carolina at Chapel Hill · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study is to explore the associations between the patient-reported Edinburgh Postnatal Depression Scale (EPDS) and Patient Health Questionnaire (PHQ)-9 and clinician-reported 17-item Hamilton Depression Rating Scale (HAMD-17) in order to facilitate clinical decision-making. An integrated efficacy dataset of three randomized placebo-controlled trials (NCT02614547, NCT02942004, and NCT02942017) evaluating brexanolone injection, a neuroactive steroid chemically identical to allopregnanolone, in women with postpartum depression was used for this post hoc analysis. Data were pooled across treatment arms. Associations were assessed at day 30 (end-of-trial follow-up). Pearson correlation assessed the relationship between EPDS and PHQ-9 item and total scores and HAMD-17 total score. Cohen's kappa assessed agreement of EPDS remission (score < 10) and PHQ-9 remission (score < 5) with HAMD-17 remission (score ≤ 7). Ordinary least squares (OLS) regression models were used to develop equations estimating HAMD-17 total scores from EPDS and PHQ-9 scores, respectively. The total scores showed large correlations (HAMD-17/EPDS: r = 0.71, p < 0.001; HAMD-17/PHQ-9: r = 0.75, p < 0.001). Individual EPDS and PHQ-9 items significantly correlated (r= 0.35 to 0.67, all p < 0.001) with HAMD-17 total score. EPDS had 79% sensitivity and 67% specificity to detect HAMD-17 remission; corresponding estimates for PHQ-9 were 76% and 78%. OLS models yielded the following equations: HAMD-17 total = 2.66 + (EPDS total × 0.87) and HAMD-17 total = 3.99 + (PHQ-9 total × 0.97). There were large and statistically significant associations between patient-reported outcomes (EPDS, PHQ-9) and clinician-reported outcomes (HAMD-17) as clinical improvements were associated with patient-reported symptom improvement. These results provide tools to help translate clinical trial data to clinical practice, thus aiding shared decision-making for this critical population.

Indexed as

Patient Reported Outcome MeasuresAdultbeta-CyclodextrinsDepression, PostpartumDrug CombinationsFemaleHumansMass ScreeningPatient Health QuestionnairePregnanolonePsychiatric Status Rating ScalesSensitivity and SpecificitySeverity of Illness IndexSurveys and Questionnairesbeta-CyclodextrinsbrexanoloneDrug CombinationsPregnanoloneEdinburgh Postnatal Depression ScaleHamilton Depression Rating ScalePatient Health Questionnaire-9Postpartum depressionPostpartum depression screening

Identifiers

PMID32666402
PMCPMC7497318
OpenAlexW3043200814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.